相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend
Kevin H. Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
S. Tan et al.
CURRENT CANCER DRUG TARGETS (2012)
From crucial to negligible: Functional CD8+ T-cell responses and their dependence on CD4+ T-cell help
Melanie Wiesel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis
Maura L. Gillison et al.
VACCINE (2012)
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value
Niladri Ganguly
CELLULAR ONCOLOGY (2012)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
A Role for HPV16 E5 in Cervical Carcinogenesis
John P. Maufort et al.
CANCER RESEARCH (2010)
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy
Deborah M. Brown
CELLULAR IMMUNOLOGY (2010)
A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Angelika B. Riemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction
Morten Nielsen et al.
BMC BIOINFORMATICS (2009)
A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells
Xuelian Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
被撤回的出版物: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells (Retracted article. See vol. 76, pg. 2490, 2016)
Kimberly A. Shafer-Weaver et al.
CANCER RESEARCH (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytotoxic human CD4+ T cells
Pablo J. van de Berg et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
J. Visser et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillornavirus antigens
Sjoerd H. van der Burg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+T cells from healthy young women
Kathleen M. E. Gallagher et al.
JOURNAL OF GENERAL VIROLOGY (2007)
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions
Shiwen Peng et al.
CLINICAL CANCER RESEARCH (2007)
Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls
Aagje G. Bais et al.
MEDIATORS OF INFLAMMATION (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma
JH Zhou et al.
LIFE SCIENCES (2006)
Detection of human papillomavirus type 18 E6 and E7-specific CD4+T-helper 1 immunity in relation to health versus disease
MJP Welters et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Developing and maintaining protective CD8(+) memory T cells
Matthew A. Williams et al.
IMMUNOLOGICAL REVIEWS (2006)
The epidemiology of human papillomavirus infections
JG Baseman et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
ZYC101a for treatment of high-grade cervical intralepithelial neoplasia: A randomized controlled trial
F Garcia et al.
OBSTETRICS AND GYNECOLOGY (2004)
The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development
SH van der Burg et al.
VIRUS RESEARCH (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Immunobiology of papillomavirus infections
MA Stanley
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2001)
Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens
M Nakagawa et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma
ME Ressing et al.
JOURNAL OF IMMUNOTHERAPY (2000)